Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

This study is currently recruiting participants.
Verified September 2013 by Ain Shams University
Sponsor:
Information provided by (Responsible Party):
Iman Fawzy Montasser, Ain Shams University
ClinicalTrials.gov Identifier:
NCT01784497
First received: February 2, 2013
Last updated: September 8, 2013
Last verified: September 2013
  Purpose

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation


Condition
Health Related Quality of Life

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Ain Shams University:

Primary Outcome Measures:
  • Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score. [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Impact of post transplant medical and psychiatric complications on quality of life [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 30
Study Start Date: January 2013
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Recipients of Living Donor Liver Transplantation
Patients who will undergo Living Donor Liver Transplantation (LDLT) In Ain Shams Center For Organ Transplantation (ASCOT) .

Detailed Description:

This Study Aims to Evaluate:-

  1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.
  2. Impact of post transplant medical and psychiatric complications on quality of life
  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients who will undergo LDLT In Ain Shams Center For Organ Transplantation (ASCOT) in the next 6 months.

Criteria

Inclusion Criteria:

  • Adult Egyptian patients
  • 18-60 years old
  • Patients transplanted for HCV related disease and /or HCC
  • Informed consent

Exclusion Criteria:

  • Other etiologies for end stage liver disease (such as HBV and cholestatic liver disease and autoimmune hepatitis).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01784497

Locations
Egypt
Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university Recruiting
Cairo, Egypt
Contact: Iman MF Montasser, MD    +201065065333      
Contact: Mahmoud A E, Professor    +201222129686    mmeteini@gmail.com   
Principal Investigator: Iman MF Montasser, MD         
Principal Investigator: Eman EL Gendy, Professor         
Sub-Investigator: Mahmoud A El Meteini, Professor         
Sub-Investigator: Hany M Dabbous, MD         
Sub-Investigator: Reem Hashem, MD         
Sub-Investigator: Mohammed A Sakr, Professor         
Sub-Investigator: Peter w Khalil, M.BB.ch.         
Sponsors and Collaborators
Ain Shams University
  More Information

No publications provided

Responsible Party: Iman Fawzy Montasser, Lecturer of tropical medicine , Ain Shams university, Ain Shams University
ClinicalTrials.gov Identifier: NCT01784497     History of Changes
Other Study ID Numbers: PostTransplant Quality of life
Study First Received: February 2, 2013
Last Updated: September 8, 2013
Health Authority: Ministry of Health,organ transplantation committee,Egypt':'

Keywords provided by Ain Shams University:
Health Related Quality of Life (HRQL)
Living Donor Liver Transplantation(LDLT)

ClinicalTrials.gov processed this record on April 17, 2014